jCyte, Inc.
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2012-01-10
- Employees
- 11
- Market Cap
- -
- Website
- http://www.jcyte.com
Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
- Conditions
- Retinitis Pigmentosa
- Interventions
- Biological: human retinal progenitor cellsOther: Mock injection
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- jCyte, Inc
- Target Recruit Count
- 60
- Registration Number
- NCT06912633
- Locations
- πΊπΈ
Retina Consultants Medical Group, Sacramento, California, United States
πΊπΈIllinois Retina Associates, Oak Park, Illinois, United States
πΊπΈCalifornia Retina Consultants, Bakersfield, California, United States
Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa
- Conditions
- Retinitis Pigmentosa
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- jCyte, Inc
- Target Recruit Count
- 30
- Registration Number
- NCT04604899
- Locations
- πΊπΈ
Gavin Herbert Eye Inst, Univ Cal Irvine, Irvine, California, United States
πΊπΈRetina-Vitreous Associates Medical Group, Los Angeles, California, United States
πΊπΈOphthalmic Consultants of Boston, Boston, Massachusetts, United States
Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa
- Conditions
- Retinitis Pigmentosa
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- jCyte, Inc
- Target Recruit Count
- 84
- Registration Number
- NCT03073733
- Locations
- πΊπΈ
Gavin Herbert Eye Inst, Univ Cal Irvine, Irvine, California, United States
πΊπΈRetina-Vitreous Associates Medical Group, Los Angeles, California, United States
πΊπΈOphthalmic Consultants of Boston, Boston, Massachusetts, United States
Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa
- Conditions
- Retinitis Pigmentosa (RP)
- First Posted Date
- 2014-12-19
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- jCyte, Inc
- Target Recruit Count
- 28
- Registration Number
- NCT02320812
- Locations
- πΊπΈ
The Gavin Herbert Eye Institute, Univ California Irvine, Irvine, California, United States
πΊπΈRetina-Vitreous Associates Medical Group, Los Angeles, California, United States